Studies on indomethacin acute toxicity and absorption

Area of Science:

• Pharmacology
• Materials Science
• Toxicology

Background:

• Indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), exists in multiple crystalline forms.
• Only the gamma crystalline form of indomethacin is approved for therapeutic use.
• Understanding the influence of crystalline polymorphism on drug properties is crucial for pharmaceutical development.

Purpose of the Study:

• To investigate the correlation between indomethacin crystalline forms (alpha and gamma) and their acute toxicity and absorption.
• To assess species-specific differences in the effects of indomethacin crystalline forms.

Main Methods:

• Experiments were conducted on mice and rats.
• Acute toxicity and absorption of different indomethacin crystalline forms were evaluated.

Main Results:

• Significant differences in toxic activity were observed between the alpha and gamma forms of indomethacin in mice.
• In rats, no significant influence of the crystalline form on indomethacin's toxicity or absorption was detected.

Conclusions:

• The crystalline form of indomethacin can influence its toxicological profile, with effects being species-dependent (observed in mice, not rats).
• Crystalline polymorphism of indomethacin does not appear to affect its absorption in either mice or rats.
• These findings highlight the importance of considering crystalline form in drug safety assessments.